Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103-1126.
Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999;354:667-672.
Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;13:462-481.
Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010;10:84-89.
Parker SR, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011;29:69-79.
1. Berger TG, James WD, Elston DM. Andrew's diseases of the skin, clinical dermatology, 10th edition. WB Saunders; 2008.
2. Harper J, Oranje A, Prose N. Textbook of pediatric dermatology, Volume 1. Blackwell Science; 2000.
3. Jaworsky C, Murphy G. Special techniques in dermatology. Arch Dermatol. 1989;125:963-974.
4. Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57:22-121.
5. Lowy G. Sexually transmitted diseases in children. Pediatr Dermatol. 1992;9:329-334.
6. Bolognia J, Jorizzo JL, Rapini RP. Dermatology, 2nd edition, volume 1. Philadelphia, PA: Mosby Saunders; 2008.
7. Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J. 1958;79:615-621.
8. Wozniacka A, Hawro T, Schwartz RA. Bullous scabies: a diagnostic challenge. Cutis. 2008;82:350-352.
9. Weinstock MA, Kempton SA. Case report: teledermatology and epiluminescence microscopy for the diagnosis of scabies. Cutis. 2000;66:61-62.
10. Uitto J, Richard G. Progress in epidermolysis bullosa: genetic classifications and clinical implications. Am J Med Genet C Semin Med Genet. 2004;131C:61-74.
11. Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103-1126.
12. Elder DE, Elenitsas R, Johnson BL Jr, et al. Lever's histopathology of the skin. 10th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
13. Ramdial PK, Naidoo DK. Drug-induced skin pathology. J Clin Pathol. 2009;62:493-504.
14. Hoeger PH, Harper JI. Neonatal erythroderma: differential diagnosis and management of the "red baby." Arch Dis Child. 1998;79:186-191.
15. Alto WA, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician. 1999;59:3047-3054, 3059-3060.
16. Lane K, Lumbang W. Pruritic blisters on legs and feet. J Fam Pract. 2008;57:177-180.
17. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999;354:667-672.
18. Yeh SW, Ahmed B, Sami N, et al. Blistering disorders: diagnosis and treatment. Dermatol Ther. 2003;16:214-223.
19. Bickle K, Roark TR, Hsu S. Autoimmune bullous disease: a review. Am Fam Physician. 2002;65:1861-1870.
20. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;13:462-481.
21. Avram MA, Gobel V, Sepehr A. Case 30-2007: a newborn girl with skin lesions. N Engl J Med. 2007;357:1327.
22. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342:635-645.
23. Howell ER, Phillips CM. Cutaneous manifestations of Staphylococcus aureus disease. Skinmed. 2007;6:274-279.
24. Fisler RE, Saeb M, Liang MG, et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol. 2003;25:183-189.
25. Muller UR, Haeberli G. The problem of anaphylaxis and mastocytosis. Curr Allergy Asthma Rep. 2009;9:64-70.
26. Meuwissen ME, Mancini GM. Neurological findings in incontinentia pigmenti: a review. Eur J Med Genet. 2012;55:323-331.
27. Hendricks WM. Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol. 1991;10:282-292.
28. Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol. 1994;11:293-303.
29. Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci. 2008;49:21-31.
30. Sweeney SM, Wiss K, Mallory SB. Inflammatory tinea pedis/manuum masquerading as bacterial cellulitis. Arch Pediatr Adolesc Med. 2002;156:1149-1152.
31. Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010;10:84-89.
32. Parker SR, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011;29:69-79.
33. Diaz LA, Giudice GJ. End of the century overview of skin blisters. Arch Dermatol. 2000;136:106-112.
34. Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345-1351.
35. Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis. 1997;16:851-854.
36. Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis. 2005;40:38-45.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台